DEF 14A

Company

ATOSSA THERAPEUTICS, INC.

Filed

April 13, 2017

Period of Report

May 9, 2017

Accession Number

0001615774-17-001655

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →